August 1st, 2018 Codex Biosolutions attain grant to identify cellular factors that modulate production of HIV-1 envelope spike. This research will be conducted over a 24 month period from September 15th, 2018 to July 15th, 2020.
July 26th, 2018. Codex Biosolutions proposed a contract to identify the cellular factors that modulate production of HIV-1 envelope spike.
March 10th, 2017. Award granted to Codex Biosolutions to improve production of full-length native HIV-1 envelope spike
The National Institute of Health (NIH) granted Codex Biosolutions with a grant of $223,073 to the principal investigator Jianming Lu, PHD in order to further develop HIV research.